[Form 4] KORU Medical Systems, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Joseph M. Manko Jr., a director and reported 10% owner, filed a Form 4 for KORU Medical Systems, Inc. (KRMD). The filing shows a transaction dated 09/30/2025 where he acquired 3,916 shares of Common Stock at a reported price of $0, and reports 5,871,335 shares beneficially owned indirectly through Horton Capital Partners Fund, LP. The Form also reports a disposition of 517,200 shares.

The Form 4 is signed by Mr. Manko with signature dates of 10/02/2025. The filing references an Exhibit 99.1 for explanations of two notes tied to the reported acquisition and indirect ownership. No additional financial metrics, option holdings, or exercise/expiry dates are disclosed in the filing text provided.

Positive

• Director status and 10% ownership disclosed, providing transparency on insider stake
• Indirect beneficial ownership of 5,871,335 shares is clearly reported

Negative

• Disposition of 517,200 shares was reported, indicating a significant sale
• Key explanations are deferred to Exhibit 99.1, so the filing alone lacks full context for the $0 acquisition and indirect ownership

Insights

Insider Transactions Specialist

Director reports an indirect holding of 5,871,335 shares and a sale of 517,200 shares.

The Form 4 shows a 09/30/2025 acquisition of 3,916 shares at $0 and an offsetting reported disposition of 517,200 shares. These entries document changes in beneficial ownership and show the reporting person holds a material indirect stake via Horton Capital Partners Fund, LP.

The filing cites Exhibit 99.1 for details on note (1) and note (2); those exhibit details are required to fully interpret the $0 acquisition and the nature of the indirect ownership.

Corporate Governance Analyst

Filing confirms director status and >10% affiliation, signaling concentrated insider ownership.

The reporting person is identified as both a director and a 10% owner, which is material for governance and disclosure purposes. The signature blocks dated 10/02/2025 complete the required attestations but the filing explicitly references an exhibit for explanatory detail.

Because the Form references Exhibit 99.1 for key notes, investors should consult that exhibit to understand the legal and economic character of the reported transactions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Manko Joseph M. Jr.

(Last) (First) (Middle)

1717 ARCH STREET

37TH FLOOR

(Street)

PHILADELPHIA PA 19103

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
KORU Medical Systems, Inc. [ KRMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/30/2025		A		3,916	A	$0(1)	5,871,335	I	By Horton Capital Partners Fund, LP(2)
Common Stock								517,200	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person^*

Manko Joseph M. Jr.

(Last) (First) (Middle)

1717 ARCH STREET

37TH FLOOR

(Street)

PHILADELPHIA PA 19103

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Horton Capital Management, LLC

(Last) (First) (Middle)

1717 ARCH STREET

37TH FLOOR

(Street)

PHILADELPHIA PA 19103

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Horton Capital Partners, LLC

(Last) (First) (Middle)

1717 ARCH STREET

37TH FLOOR

(Street)

PHILADELPHIA PA 19103

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Horton Capital Partners Fund, L.P.

(Last) (First) (Middle)

1717 ARCH STREET

37TH FLOOR

(Street)

PHILADELPHIA PA 19103

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

Explanation of Responses:

1. See Exhibit 99.1 to this Form 4 for explanation of note (1).

2. See Exhibit 99.1 to this Form 4 for explanation of note (2).

Remarks:

The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person.

	/s/ Joseph M. Manko, Jr.	10/02/2025
	/s/ Joseph M. Manko, Jr., Managing Member of Horton Capital Management, LLC	10/02/2025
	/s/ Joseph M. Manko, Jr., Managing Member of Horton Capital Partners, LLC	10/02/2025
	/s/ Joseph M. Manko, Jr., Managing Member of Horton Capital Partners, LLC, the General Partner of Horton Capital Partners Fund, LP	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed the Form 4 for KORU (KRMD)?

The Form 4 was filed by Joseph M. Manko Jr., who is identified as a director and a 10% owner.

What transactions are reported on the Form 4 for KRMD?

The filing reports an acquisition of 3,916 common shares at $0 on 09/30/2025 and a reported disposition of 517,200 common shares.

How many KORU shares does the reporting person beneficially own?

The filing reports 5,871,335 shares beneficially owned indirectly through Horton Capital Partners Fund, LP.

When was the Form 4 signed?

The signature lines show dates of 10/02/2025 for Joseph M. Manko Jr. and related entities.

Where can I find explanations of the notes referenced in the Form 4?

The Form 4 references Exhibit 99.1 for explanations of note (1) and note (2); those exhibit(s) must be consulted for full details.